Guilaine Boursier

机构：Inserm, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Institute for Regenerative Medicine & Biotherapy, Centre de Référence des Maladies Autoinflammatoires et des Amyloses · ORCID：0000-0002-2903-3135

发表论文 116 篇 · 总被引 2276 次 · h-index 24

代表论文

• Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants (2025 · Nature Immunology · 被引 84)
• PFMG2025–integrating genomic medicine into the national healthcare system in France (2025 · The Lancet Regional Health - Europe · 被引 48)
• Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX (2025 · Blood · 被引 37)
• Regulating the future of laboratory medicine: European regulatory landscape of AI-driven medical device software in laboratory medicine (2025 · Clinical Chemistry and Laboratory Medicine (CCLM) · 被引 21)
• EN ISO 15189 revision: EFLM Committee Accreditation and ISO/CEN standards (C: A/ISO) analysis and general remarks on the changes (2025 · Clinical Chemistry and Laboratory Medicine (CCLM) · 被引 15)
• How (Ultra‐)Rare Gene Variants Improve Our Understanding of More Common Autoimmune and Inflammatory Diseases (2025 · ACR Open Rheumatology · 被引 8)